Elevated triglyceride-glucose (TyG) index is associated with increased risk of major adverse cardiovascular events (MACEs) in patients with coronary heart disease (CHD), regardless of diabetes status.
The TyG index predicts all-cause mortality, nonfatal myocardial infarction, and revascularization in both diabetic and nondiabetic CHD populations.
Nonfatal stroke is significantly linked with TyG index only in diabetic CHD patients, not in those without diabetes.
This study supports the TyG index as a potential prognostic marker in CHD but highlights the need for further prospective validation.
